hotspot -WSS

hotspot

author：knowledge 2025-09-27 23:07:54 Page View：4

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Senate committee advances SCOTUS ethics bill after alleged justice misconduct
Next article： Apple is now the first public company to be valued at $3 trillion

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

RSV vaccines may be linked to small increased risk of developing GBS

CourtesyPfizerThenewvaccinesthatprotectolderadultsagainstrespiratorysyncytialvirus,orRSV,maybelinked

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

How to fix the rural physician shortage in the U.S.

AdobeAsthedeansofthetwopublicmedicalschoolsinNevada,wearewatchingwithprideasourrecentgraduatesprepar

hotspot

explore

leisure time

How to fix the rural physician shortage in the U.S.